Why Pfizer Stock Slumped on Friday
In the midst of the coronavirus pandemic a few years ago, any positive news from a COVID-19 vaccine or drug developer would have been met with a surge in buying of its shares. But it’s not 2021 anymore, and there’s an encouraging…